Hoxworth offering e-gift cards for donors to boost blood supply
In an effort to boost the local blood supply ahead of the busy holiday season, Hoxworth Blood Center is offering all donors a $10 e-gift card between Nov. 2 and Nov. 8.
Individuals who donate blood, platelets, or plasma between Monday, Nov. 2 and Sunday, Nov. 8 will receive a $10 e-gift card.
“The need for blood continues to increase at local hospitals as surgeries that were postponed during the beginning of the pandemic are rescheduled, and beyond that, we never know what sort of traumas or emergency situations will require massive amounts of blood products,” said Alecia Lipton, director of public relations at Hoxworth Blood Center. “We’re asking eligible donors to plan their next donation as soon as possible.”
Donors will receive an email with their e-gift card link within 48 hours of their donation and can select from a number of restaurants, retail stores and services.
Blood banks across the United States are gearing up for a difficult several weeks, said Lipton. Flu season and busy holiday schedules historically negatively impact donor turnout, and recent spikes in COVID-19 cases are also expected to cause complications for potential donors.
Hoxworth continues to follow social distancing guidelines at donor centers and blood drives. Masks are required per local guidelines.
To schedule a donation, call (513) 451-0910 or visit www.hoxworth.org. Appointments are requested at this time in order to maintain social distancing protocol.
About Hoxworth
Hoxworth Blood Center, University of Cincinnati was founded in 1938 and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 90,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home.
Related Stories
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Breakthrough skin science discovery
March 12, 2026
A research collaboration between the University of Cincinnati and global cosmetics company Kose led to the creation of a novel anti aging spot fading serum.